Progress in Evaluation of Pathologic Response to Neoadjuvant Chemotherapy of Breast Cancer

E-ISSN： 1875-5992|13|2|222-226

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.13, Iss.2, 2013-02, pp. : 222-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 211-213

Informa Healthcare

Access to resources Recommend Favorite

Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy

By Schott Anne

Breast Cancer Research and Treatment, Vol. 92, Iss. 3, 2005-08 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple‐negative breast cancer

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 500-506

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [ 18 F]-fluorodeoxyglucose positron emission tomography

By Burcombe R.J. Makris A. Pittam M. Lowe J. Emmott J. Wong W.L.

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 375-379

Elsevier

Access to resources Recommend Favorite

Evaluation of dynamic contrast-enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

By Wang Xiaohong Peng Weijun Tan Hongna Xin Chao Mao Jian

The Chinese-German Journal of Clinical Oncology, Vol. 9, Iss. 11, 2010-11 ,pp. : 637-642

Springer Publishing Company

Access to resources Recommend Favorite